Welcome to LookChem.com Sign In|Join Free

CAS

  • or

107377-07-1

Post Buying Request

107377-07-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

107377-07-1 Usage

General Description

4-N-butylbenzamide is a chemical compound with the molecular formula C11H15NO. It is a derivative of benzamide, with a butyl group attached to the nitrogen atom. 4-N-BUTYLBENZAMIDE is commonly used in research and industrial applications as a building block for the synthesis of other organic compounds. It has also been studied for its potential pharmaceutical properties, including its ability to interact with receptors in the central nervous system. 4-N-butylbenzamide is typically produced through organic synthesis methods and is a white to off-white crystalline solid at room temperature.

Check Digit Verification of cas no

The CAS Registry Mumber 107377-07-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,3,7 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 107377-07:
(8*1)+(7*0)+(6*7)+(5*3)+(4*7)+(3*7)+(2*0)+(1*7)=121
121 % 10 = 1
So 107377-07-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H15NO/c1-2-3-4-9-5-7-10(8-6-9)11(12)13/h5-8H,2-4H2,1H3,(H2,12,13)

107377-07-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A19516)  4-n-Butylbenzamide, 97%   

  • 107377-07-1

  • 1g

  • 157.0CNY

  • Detail
  • Alfa Aesar

  • (A19516)  4-n-Butylbenzamide, 97%   

  • 107377-07-1

  • 5g

  • 608.0CNY

  • Detail
  • Alfa Aesar

  • (A19516)  4-n-Butylbenzamide, 97%   

  • 107377-07-1

  • 25g

  • 2552.0CNY

  • Detail

107377-07-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-butylbenzamide

1.2 Other means of identification

Product number -
Other names 4-Butyl-benzoesaeure-amid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:107377-07-1 SDS

107377-07-1Relevant articles and documents

Copper-catalyzed aerobic oxidative C-C bond cleavage for C-N bond formation: From ketones to amides

Tang, Conghui,Jiao, Ning

, p. 6528 - 6532 (2014)

A novel copper-catalyzed aerobic oxidative C(CO)-C(alkyl) bond cleavage reaction of aryl alkyl ketones for C-N bond formation is described. A series of acetophenone derivatives as well as more challenging aryl ketones with long-chain alkyl substituents could be selectively cleaved and converted into the corresponding amides, which are frequently found in biologically active compounds and pharmaceuticals.

Visible Light-Induced Iodine-Catalyzed Transformation of Terminal Alkynes to Primary Amides via C≡C Bond Cleavage under Aqueous Conditions

Dighe, Shashikant U.,Batra, Sanjay

supporting information, p. 500 - 505 (2016/02/12)

The visible light-induced iodine-catalyzed oxidative cleavage of the C≡C bond for transforming terminal alkynes into primary amides in the presence of ammonia under aqueous conditions is described. This metal-free protocol which ensued via initial hydroamination of the acetylene bond followed by liberation of diiodomethane (CH2I2) was found to be applicable to aromatic, heteroaromatic and aliphatic alkynes.

Discovery and characterization of potent thiazoles versus methicillin- and vancomycin-resistant Staphylococcus aureus

Mohammad, Haroon,Mayhoub, Abdelrahman S.,Ghafoor, Adil,Soofi, Muhammad,Alajlouni, Ruba A.,Cushman, Mark,Seleem, Mohamed N.

, p. 1609 - 1615 (2014/03/21)

Methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA) infections are growing global health concerns. Structure-activity relationships of phenylthiazoles as a new antimicrobial class have been addressed. We present 10 thiazole derivatives that exhibit strong activity against 18 clinical strains of MRSA and VRSA with acceptable PK profile. Three derivatives revealed an advantage over vancomycin by rapidly eliminating MRSA growth within 6 h, and no derivatives are toxic to HeLa cells at 11 μg/mL.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 107377-07-1